FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Boehringer Ingelheim Roxane Acarbose Tablets 50 mg a)10 x 10 Unit Dose Recall

Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottle…

Boehringer Ingelheim Roxane Inc · Columbus, OH

Risk level
Class II
Reported by FDA
Jun 3, 2015
Recall ID
D-1085-2015
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Roxane recalled Acarbose Tablets 50 mg a)10 x 10 Unit Dose starting Apr 2, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1085-2015 on Jun 3, 2015. Reason: Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point. Status: Completed.

Why it was recalled

Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.

Product description

Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25

Lot numbers, UPCs & expiration codes

a) Lot # 460073A Exp 04/2016 b) Lot # 460073B Exp 04/2016

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1085-2015
Classification
Class II
Status
Completed
Recall initiated
Apr 2, 2015
FDA report date
Jun 3, 2015
Quantity
a) 575 Blister Packs, b) 12,802 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Roxane Inc

Original FDA data

Every field from FDA enforcement report D-1085-2015, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Completed
Country
United States
Event ID
70990
Address
1809 Wilson Rd
Code information
a) Lot # 460073A Exp 04/2016 b) Lot # 460073B Exp 04/2016
Postal code
43228-9579
Report date
Jun 3, 2015
Product type
Drugs
Recall number
D-1085-2015
Classification
Class II
Recalling firm
Boehringer Ingelheim Roxane Inc
Product quantity
a) 575 Blister Packs, b) 12,802 Bottles
Termination date
Feb 19, 2016
Reason for recall
Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Apr 2, 2015
Initial firm notification
Letter
Center classification date
May 27, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1085-2015, published Jun 3, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls